| 2009 | | Factors associated with liver stiffness in chronic liver disease | 김영배, 정재연, 조성원 |
| 2002 | | H. pylori Infection and Gastric Carcinogenesis | 김명욱, 김영배, 김진홍, 이기명, 정재연, 조성원, 조용관, 주희재, 최준혁, 한상욱, 함기백 |
| 2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
| 2007 | | Liver Stiffness Measurement for the Diagnosis of Hepatic Fibrosis in Patients with Chronic Viral Hepatitis | 김영배, 정재연, 조성원 |
| 2010 | | Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. | 김영배, 여말희, 이광재, 정재연, 조성원 |
| 2005 | | MR findings in eosinophilic infiltration of the liver. | 김영배, 김재근, 선주성, 원제환, 이기명, 정재연 |
| 2011 | | Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C | 김영배, 정재연, 조성원 |
| 2011 | | Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. | 김영배, 정재연, 조성원 |
| 2012 | | Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B | 김순선, 김영배, 정재연, 조성원 |
| 2014 | | Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B | 김순선, 김영배, 박주한, 안선주, 정재연, 조성원, 조효정 |
| 2018 | | Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis | 김순선, 김영배, 정재연, 조성원 |
| 2010 | | The prevalence of significant fibrosis in chronic hepatitis B patients with ALT | 김영배, 정재연, 조성원 |
| 2011 | | Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B. | 김영배, 정재연, 조성원 |
